Dr. Jedd Wolchok to lead Meyer Cancer Center
Source: Cornell Chronicle, August 2022
Dr. Jedd Wolchok, an internationally acclaimed medical oncologist whose innovations in immunotherapy have revolutionized melanoma treatment, has been recruited as the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, effective Sept. 12.
In his new role, Wolchok will lead an expansive, multidisciplinary research and clinical enterprise dedicated to translating groundbreaking discoveries on the underlying causes of cancer into cutting-edge treatment approaches and personalized therapies to improve patient outcomes. Wolchok will also expand the exemplary care delivered at the institution’s flagship Upper East Side Manhattan location and further enhance care for patients in Brooklyn and Queens.
Wolchok currently serves as chief of the Immuno-Oncology Service and the Lloyd J. Old /Virginia and Daniel K. Ludwig Chair in Clinical Investigation at Memorial Sloan Kettering Cancer Center (MSK), and he is a professor of medicine at Weill Cornell Medicine. He succeeds Dr. Massimo Loda, chair of the Department of Pathology and Laboratory Medicine at Weill Cornell Medicine, who has served as interim director since last year’s departure of Dr. Lewis Cantley, the center’s founding Meyer Director.